| Dispensed a urate-lowering therapy |
This measure shows the percentage of people with identified gout who received urate-lowering therapy at least once in a year. Long-term urate-lowering therapy is used to prevent gout flares and prevent tophus formation, bony erosions and permanent disability in people with gout. Many studies have demonstrated underutilisation of urate-lowering therapy continuously and long term. |
National Minimum Dataset, Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Mortality Collection, NZ Cancer Registry, Ministry of Health, National Population Projection - Stats NZ |
Health Quality & Safety Commission | Te Tāhū Hauora |
|
